Metagenomi Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Thomas Brian C. | — | Sale | 3,830 | $1.77 | $6,779 | 2,510,960 | Dec 5, 2025 |
| Wein Matthew | See Remarks | Sale | 199 | $1.77 | $352 | 115,031 | Dec 5, 2025 |
| Wapnick Pamela | Chief Financial Officer | Sale | 1,576 | $1.77 | $2,790 | 188,956 | Dec 5, 2025 |
| Irish Jian | Chief Executive Officer | Sale | 1,602 | $1.77 | $2,836 | 563,839 | Dec 5, 2025 |
| Irish Jian | Chief Executive Officer | Award / Grant | 211,000 | $1.60 | $337,600 | 565,441 | Dec 1, 2025 |
| Thomas Brian C. | — | Sale | 2,701 | $1.81 | $4,889 | 2,514,790 | Sep 5, 2025 |
| Wapnick Pamela | Chief Financial Officer | Award / Grant | 120,000 | $1.60 | $192,000 | 190,532 | Sep 5, 2025 |
| Wein Matthew | See Remarks | Award / Grant | 96,000 | $1.60 | $153,600 | 115,230 | Sep 5, 2025 |
| Wein Matthew | See Remarks | Sale | 199 | $1.75 | $348 | 16,693 | Jun 6, 2025 |
| Noonberg Sarah B. | Chief Medical Officer | Sale | 5,239 | $1.75 | $9,168 | 109,135 | Jun 6, 2025 |
| Wapnick Pamela | Chief Financial Officer | Sale | 1,576 | $1.75 | $2,758 | 72,108 | Jun 6, 2025 |
| Thomas Brian C. | Chief Executive Officer | Sale | 10,785 | $1.75 | $18,874 | 2,517,491 | Jun 6, 2025 |
| Irish Jian | See Remarks | Sale | 6,390 | $1.75 | $11,183 | 315,543 | Jun 6, 2025 |
| Wapnick Pamela | Chief Financial Officer | Award / Grant | 14,000 | — | — | 73,684 | Apr 1, 2025 |
| Thomas Brian C. | Chief Executive Officer | Award / Grant | 32,000 | — | — | 2,528,276 | Apr 1, 2025 |
| Irish Jian | See Remarks | Award / Grant | 23,000 | — | — | 321,933 | Apr 1, 2025 |
| Wein Matthew | See Remarks | Award / Grant | 3,650 | — | — | 13,117 | Apr 1, 2025 |
| Noonberg Sarah B. | Chief Medical Officer | Award / Grant | 14,000 | — | — | 114,374 | Apr 1, 2025 |
| Wein Matthew | See Remarks | Sale | 930 | $1.87 | $1,739 | 9,467 | Mar 5, 2025 |
| Wapnick Pamela | Chief Financial Officer | Sale | 1,808 | $1.87 | $3,381 | 59,684 | Mar 5, 2025 |
| Wapnick Pamela | Chief Financial Officer | Sale | 1,559 | $1.86 | $2,900 | 61,492 | Dec 5, 2024 |
| Wapnick Pamela | Chief Financial Officer | Sale | 6,265 | $2.88 | $18,043 | 63,051 | Sep 5, 2024 |
| Harnest Simon | See Remarks | Award / Grant | 11,552 | — | — | 122,664 | Apr 1, 2024 |
| Irish Jian | See Remarks | Award / Grant | 70,471 | — | — | 298,933 | Apr 1, 2024 |
| Borges Luis | Chief Scientific Officer | Award / Grant | 69,316 | — | — | 69,316 | Apr 1, 2024 |
| Wein Matthew | See Remarks | Award / Grant | 10,397 | — | — | 10,397 | Apr 1, 2024 |
| Wapnick Pamela | Chief Financial Officer | Award / Grant | 69,316 | — | — | 69,316 | Apr 1, 2024 |
| Noonberg Sarah B. | Chief Medical Officer | Award / Grant | 57,763 | — | — | 100,374 | Apr 1, 2024 |
| Delaney Simren | See Remarks | Award / Grant | 6,931 | — | — | 93,892 | Apr 1, 2024 |
| Thomas Brian C. | Chief Executive Officer | Award / Grant | 118,992 | — | — | 2,496,276 | Apr 1, 2024 |
| Novo Holdings A/S | — | C | 839,175 | — | — | 939,175 | Feb 13, 2024 |
| Bayer World Investments B.V. | — | C | 509,855 | — | — | 4,050,997 | Feb 13, 2024 |
| Bernales Sebastian | — | C | 1,896,445 | — | — | 1,896,445 | Feb 13, 2024 |